Episode Details

Welcome to episode no. 22 (August 2024) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the August 2024 issue of Diabetes Care.

0:42 Alice opens the show by reminding listeners that August 26 is the last day to access the online sessions from the 84th Scientific Sessions, which took place 21–24 June in Orlando, FL. Anyone who has registered can access the content at ada2024.org, so don't forget to check it out!

1:26: Mike hosts the first interview of the episode, with Dr. Anastasia Albanese-O'Neill and Dr. Linda A. DiMeglio, corresponding author and last author, respectively, of "Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes." This consensus report is an editor-selected feature article appearing in the August 2024 issue and is openly accessible at https://doi.org/10.2337/dci24-0042.

28:37: Alice's initial guest is Dr. Guillermo E. Umpierrez, first author of "Hyperglycemic Crises in Adults With Diabetes: A Consensus Report." This consensus report is also an editor-selected feature article in the August 2024 issue and is openly accessible at https://doi.org/10.2337/dci24-0032.

52:19: In the "Diabetes Care Rapid Exchange," Alice and Mike wrap up the episode by reviewing several interesting articles in the August 2024 issue of Diabetes Care. Studies highlighted in this segment include:

• Daultrey et al. What Is the Influence of HIV Serostatus on HbA1c? A Prospective Analysis Using Continuous Glucose Monitoring. https://doi.org/10.2337/dc24-0225
• Durnwald et al. Continuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus. https://doi.org/10.2337/dc23-2149
• Ghalwash et al. Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles. https://doi.org/10.2337/dc24-0198
• Hessler et al. EMBARK: A Randomized, Controlled Trial Comparing Three Approaches to Reducing Diabetes Distress and Improving HbA1c in Adults With Type 1 Diabetes. https://doi.org/10.2337/dc23-2452
• Kahn et al. Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial. https://doi.org/10.2337/dc24-0491
• Lingvay et al. Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT. https://doi.org/10.2337/dc24-0764
• Green et al. The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice. https://doi.org/10.2337/dci24-0001

To learn more about Diabetes Ca